NCT07689344
Poly-L-lactic Acid (PLLA) Injection for Neck Skin Laxity: A Pilot Study
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 7 more changesShow less
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Primary completion date changed from estimate of Aug 1, 2026 to Sep 15, 2026
- Study completion pushed from Sep 1, 2026 to May 15, 2027
- Start date changed from estimate of Jul 1, 2026 to Sep 15, 2026
- Secondary endpoints: details revised at 3 of 3 entries
- Site contact updated
- Publications: details revised at 4 of 4 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in Neck Skin Laxity Scale (NSL scale) Score
Timeframe: Baseline (Week 0), Week 8, Week 16, and Week 24
Secondary (3)
Participant-Reported Neck Appearance Satisfaction Score Assessed Using the 5-Point Neck Appearance Satisfaction Scale
Change in skin Firmness and Elasticity Assessed by Cutometer® Dual MPA 580
Incidence of Treatment-Related Adverse Events
Arms and interventions
PLLA InjectionExperimental
Participants will receive a single treatment session of Poly-L-Lactic acid (PLLA) injection for the treatment of neck skin laxity. PLLA will be administered to the neck using a cannula technique in the subcutaneous plane. Approximately 16 mL of PLLA solution will be injected per participants. Clinical outcomes will be evaluated at baseline and during follow-up visits at Weeks 8, 16, and 24.
Drugs: Poly-L-Lactic Acid (Sculptra) injection
Sites
1 site in 1 country
- Institute of DermatologyRatchathewi, Bangkok, Thailand